174 related articles for article (PubMed ID: 24351818)
1. The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.
Chen J; Huang GD; Tan SR; Guo J; Su ZQ
Int J Mol Sci; 2013 Dec; 14(12):24305-19. PubMed ID: 24351818
[TBL] [Abstract][Full Text] [Related]
2. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
3. Eudragit coating of chitosan-prednisolone conjugate microspheres and in vitro evaluation of coated microspheres.
Onishi H; Oosegi T; Machida Y; McGinity JW
Drug Dev Ind Pharm; 2007 Aug; 33(8):848-54. PubMed ID: 17729102
[TBL] [Abstract][Full Text] [Related]
4. Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.
Oosegi T; Onishi H; Machida Y
Eur J Pharm Biopharm; 2008 Feb; 68(2):260-6. PubMed ID: 17703928
[TBL] [Abstract][Full Text] [Related]
5. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
6. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
Hosny EA; el-Mahrouk GM; Gouda MW
Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
[TBL] [Abstract][Full Text] [Related]
7. Sustained release enteric coated tablets of pantoprazole: formulation, in vitro and in vivo evaluation.
Wilson B; Babubhai PP; Sajeev MS; Jenita JL; Priyadarshini SR
Acta Pharm; 2013 Mar; 63(1):131-40. PubMed ID: 23482318
[TBL] [Abstract][Full Text] [Related]
8. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
Chen MM; Wang CR; Jin Y
Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
[TBL] [Abstract][Full Text] [Related]
11. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
12. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
13. Colon-specific drug delivery for mebeverine hydrochloride.
Omar S; Aldosari B; Refai H; Gohary OA
J Drug Target; 2007 Dec; 15(10):691-700. PubMed ID: 18041637
[TBL] [Abstract][Full Text] [Related]
14. Preparation and sustained release of diatomite incorporated and Eudragit L100 coated hydroxypropyl cellulose/chitosan aerogel microspheres.
Sang Y; Gao J; Han X; Liang T; Chen T; Zhao Y
Int J Biol Macromol; 2024 May; 267(Pt 1):131447. PubMed ID: 38588843
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
Wu B; Shun N; Wei X; Wu W
Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
[TBL] [Abstract][Full Text] [Related]
16. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
17. Development and stability evaluation of enteric coated Diclofenac sodium tablets using Sureteric.
Zaid AN
Pak J Pharm Sci; 2012 Jan; 25(1):59-64. PubMed ID: 22186310
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
19. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of release from enteric-coated tablets.
Ozturk SS; Palsson BO; Donohoe B; Dressman JB
Pharm Res; 1988 Sep; 5(9):550-65. PubMed ID: 3247318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]